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Abstract-The tetanus toxin light ehain blocks ealcium induced vasopressin release from neurohypo-
physial nerve terminals. Here we show that histidine residue 233 within the putative zine binding motif 
of the tetanus toxin light chain is essential for the inhibition of ellocytosis, in the rat. The zine chelating 
agent dipicolinic acid as weil as captopril, an inhibitor of zinc-dependent peptidases, counteract the effect 
of the neurotoxin. Synthetic peptides, the sequences of which correspond to motifs present in the 
cytoplasmic domain of the synaptic vesic1e membrane protein synaptobrevin land 2, prevent the effect 
of the tetanus toxin light ehain. 
Our results indicate that zine bound to the zine binding motif constitutes the active site of the tetanus 
toxin light chain. Moreover they suggest that c1eavage of synaptobrevin by the neurotoxin causes the 
inhibition of exocytotic release of vasopressin from secretory granules. 
Neurons and endocrine cells release their secretory 
products by regulated exocytosis. Release of the 
contents of secretory granules and synaptic vesicles 
from neurons and endocrine cells is highly regulated 
by calcium. However, the preeise mechanism of 
calcium triggered fusion of secretory vesicles with 
the plasma membrane is still poorly understood. 
The use of cells, synaptosomes and neurosecreto-
somes which have had their plasma membrane per-
meabilized, thereby allowing passage of exogenous 
molecules, has been instrumental in the establishment 
of the regulatory effect of intracellular calcium and its 
modulation by a variety of substances (inc1uding 
cAMP, GTP, ATP, diacylglycerol and others). Per-
meabilization of ceHs also facilitated the analysis of 
the basic mechanisms underlying the inhibition of 
exocytosis by c10stridial neurotoxins such as tetanus 
and botuJinum toxins: previous experiments have 
shown that the disulfide Jinked light and heavy 
chains of c10stridial neurotoxins must be separated 
before the light chain, which harbors the active 
domain, can block calcium-evoked exocytosis by 
endocrine cells.1•2,8-10.49,51 Similarly injection into 
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Ap/ysia neurons, of either the light chain itself or 
of mRNA encoding the toxin31,37.38 inhibits exocytosis 
as does introduction of the light chains into mam-
malian eortieal and neurohypophysial nerve termi-
nals. 16,18,50 
Recently it has been reported that ineubation of 
isolated synaptic vesicles with tetanus toxin results in 
the cleavage ofthe synaptic vesicle membrane protein 
synaptobrevin_43,44 Furthermore, inhibition of gluta-
mate release from cortical synaptosomes by tetanus 
toxin was paralleled by cleavage of synaptobrevinl2 
whilst blockage of acetylcholine release from Aplysia 
neurons injected with tetanus toxin was delayed by 
peptides corresponding to the proposed synapto-
brevin 2 cleavage site.43 Transglutaminase activated 
by tetanus toxin covalently modifies synapsin I 
suggesting that synapsin I could also be a target 
of the neurotoxin.21.22 Taken together these obser-
vations indicate that the inhibition of neurotransmit-
ter release from synaptic vesicles by the tetanus 
toxin light chain may be causally linked to the 
cIeavage or covalent modification of synaptic vesicle 
proteins. 
Thc molecular structure and the sequence of most 
cIostridial neurotoxins is known.40 The light chains of 
tetanus toxin and botulinum A toxin contain a motif 
(HELIH, position 233-237) which is also present in 
a variety of zinc-dcpendent peptidases.30 Both tetanus 
and botulinum A toxin bind one atom of zinc per 
molecule44,45,59 suggesting that the neurotoxins are 
zine peptidases. 
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Release of transmitters or hormones by neurons 
and endocrine cells may occur from at least two 
different types of secretory organelles. One type, 
containing primarily amines and/or peptides, is 
characterized by an electron dense core (hence the 
term dense core vesicles, or secretory granules), whilst 
the second type, which is translucent and filled with 
dassical neurotransmitters, when present in neurons, 
is referred to as synaptic vesides. Clostridial neuro-
toxin light chains also inhibit exocytotic release of 
secretory granules1,2,8-IO.16.18.49-51 but it is not dear 
whether zinc, and the zinc binding motif within the 
light chain of tetanus toxin, are essential for the 
inhibition of secretory granule exocytosis. 
In the present study we used isolated neurohypo-
physial nerve endings as a model system to examine 
the function of the tetanus toxin light chain. In these 
nerve endings vasopressin is released from secretory 
granules. Exocytotic release of vasopressin from per-
meabilized neurohypophysial nerve endings can be 
blocked by botulinum A and tetanus toxin light 
chains. 16.18 If these toxins act as metallopeptidases, 
then we would anticipate removal of the metal eo-
factor (zine), addition of captopril, a speeifie inhibitor 
of zine peptidase activityll.15 or mutational modifi-
ca ti on of the proposed zinc binding motif to abolish 
its action. Similarly we propose that eo-ineubation of 
permeabilized neurosecretosomes with synthetie pep-
tides corresponding to the putative cleavage site of 
synaptobrevin 2 should eompetitively inhibit the 
action of clostridial neurotoxins, if synaptobrevin 
rather than synapsin I is a target of the tetanus toxin 
light chain in neurohypophysial terminals. 
EXPERIMENTAL PROCEDURES 
Isolation of neurosecretory nerve terminals 
Neurointermediate lobes were removed from the male 
Wistar rats (Charles River, Sulzfeld, Germany) of250-3oo g 
body weight, washed with Locke saline containing (in mM) 
NaCI (140), KHCOJ (5), MgCl2 (I), CaCl2 (2.2), HEPES (10), pH 7.2, glucose (10), and 0.025% bovine serum albu-
min (Sigma, Munieh, Germany). Throughout the isolation 
procedure the temperature was maintained at 37'C. Four 
neural lobes were gently homogenized by hand using a 
loose-fitting Teflon-to-glass homogenizer in I ml medium 
containing 270 mM sucrose, 10 mM HEPES (pH 7.2) and 
2 mM EGT A. The osmolarity of the media was maintained 
between 300 and 310 mosmol/kg. The nerve endings were 
then isolated as describedY Briefly, the homogenate was 
centrifuged at 100 g for Imin, and the resulting supernatant 
was further centrifuged at 2400 g for 4 min. The resulting 
pellet, containing mostly nerve endings, as judged by elec-
tron microscopy,41 was resuspended in Locke saline and 
loaded onto eight 0.45/lm filters (Acrodisc LC 13, Gelman 
Sciences, Dreieich, Germany). 
Permeabilizalion of the nerve terminals and measurement of 
vasopressin release 
The nerve terminals on the filters were perifused at 37°C 
by means of a multichannel peristaltic pump (Ismatec 
IPN-8, Zürich, Switzerland) for 45 min with Locke saline at 
a fiow rate of 50/lI/min. Subsequently the terminals were 
perifused (fiow 100/lI/min) for 10 min with Locke saline 
containing 2 mM EGT A instead of calcium and then for 
45 min with potassium glutamate medium (hereafter defined 
as medium B containing (in mM) potassium glutamate 
(150), magnesium acetate (7.0), EDTA (5), EGTA (0.5). 
PIPES (10), pH 6.8. This medium, used in all subsequent 
steps as a surrogate for the intracellular fluid, contains 
2 mM free Mg2+, which is optimal for the study of exocyto-
sis in permeabilized chromaffin cells and neurohypophysial 
nerve terminals. 17,55 For permeabilization, the nerve termi-
nals were perifused (fiow 100 /ll/min) for 5 min with strep-
tolysin ° (50 hemolytic units/ml) in medium B containing 
I mM dithiothreitol (DTT) as a reducing agent. Sub-
sequently, the terminals were perifused for 30 min (pump 
speed was reduced to minimum flow of approximately 
15/lI/min in order to economize the toxin materials used) 
with tetanus toxin light chain or different recombinants 
dissolved in medium B or with medium B alone (controls). 
The nerve terminals were then perifused (flow 100/lI/min) 
for 4 min with medium B before collection of the 
fractions. 
In some experiments tetanus toxin light chains (TeTxLs) 
(100 nM) were preincubated for 30 min at 4°C in medium B 
with 100/lM dipicolinic acid (Sigma, Munich, Germany), 
I mM captopril (Bristol-Myers Squibb, Regensburg, 
Germany), 100 /lM sodium diethyldithiocarbamate (Merck, 
Darmstadt, Germany) or 100 /lM synthetic peptides fol-
lowed by 5 min at 37°C and then exposed to the nerve 
terminals. 
Fractions of the perifusate were collected every 2 min by 
means of a microfraction collector (model 203, Gilson 
medical Electronics, Villiers le Bel, France) and immediately 
frozen until radioimmunoassay for arginine-vasopressin was 
performed. 12 Vasopressin release was triggered after 16 min 
by challenging the nerve endings with medium B sup-
plemented with 10 /lM free Ca2+. Free Ca2+ concentrations 
were calculated and controlled with a Ca2+ specific electrode 
as described reeently.24 In order to assure the response ofthe 
permeabilized nerve endings to Ca2+ and the TeTxL their 
effects were checked in each group of experiments (see 
Figures presented in this paper). 
Te/anus loxin light chains, streptolysin 0 and peptides 
The expression of recombinant light chains of tetanus 
toxin in E. coU strain MI5 using a newly synthesized gene l9 
encoding the entire light chain with six C-terminally added 
H-residues will be published elsewhere (Niemann et al. 
unpubJished observations). Mutants were generated by re-
placement of a SnaBI-Fphl restriction fragment l9 with suit-
able synthetic oligonucleotides. All mutants were 
charaeterized by DNA sequencing using the ehain termin-
ation method.42 The protein was purified from the bacterial 
lysates' on a Ni-agarose column. Recombinant light 
chain (wild type, WT), recombinants in which histidine 
(position 233) was replaced by cysteine or valine (mutants 
H233C, or H233V) were used in this study. 
Natural tetanus toxin was isolated and characterized as 
previously described.28 ,57 During toxin purification, EDTA 
(4 mM) was present in the first column step (HIC). Tetanus 
toxin was separated into its heavy and light chains by 
isoelectric focusing in a sucrose gradient with ampholyte 
under reducing conditions in 2 mol./I urea. 56 Before use in 
the purified TeTxL preparations were dialysed against 
medium B. Prior to zine determination TeTxL was incu-
bated for 5 min at 30D C in medium B or in medium B 
containing 100/lM dipicolinic acid (DPA), After concen-
tration of the protein by centrifugation for 10 min at 7000 g 
in a Centricon MG 30,000 device (Amicon, Witten, 
Germany) medium B (or medium B containing 100 /lM 
DPA) was added, centrifuged as above, and zinc was 
determined in the concentrate by atomic absorption spec-
troseopy (Zeemann-AAS 4100 ZI, Perkin-Elmer, Überlin-
gen, Germany). 
Streptolysin 0 was purified from group A streptococci 
(Richards strain) by SH-specific chromatography followed 
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by HIC chromatography (Weller et al., unpublished obser-
vation). 
The peptides QFET, ASQFETS as weil as the 20-mers 
DALQAGASVFESSAAKLKRK (peptide I) and DALQA-
GASQFETSAAKLKRK (peptide 2) were prepared by solid 
phase synthesis using an automatie synthesizer (431A, Ap-
plied Biosystems, Foster City CA, U.S.A.) employing F-
moe chemistry. The produets were detaehed from the resin 
with trifiuoroacetic acid (Sigma) and purified by reversed-
phase HPLC. The peptides were characterized by Edman 
sequeneing on a model 473A sequeneer (Applied Biosys-
tems, Foster City CA, U.S.A.). 
RESULTS 
Isolated, streptolysin O-permeabilized nerve termi-
nals perifused in the absence of calcium, released only 
low and eonstant amounts of vasopressin (Fig. 1). 
However, addition of 10 flM free calcium caused a 
several-fold inerease in vasopressin release (Fig. I, 
control). The sum of vasopressin released during the 
16 min following the elevation ofCa2+ in the medium 
was approximately four-fold higher when compared 
with the vasopressin release within the 16 min pre-
ceding the onset of Ca2+ stimulus (see controls 
shown in Figs 1-5). Pretreatment (see Experimental 
Proeedures) of the permeabilized nerve terminals for 
30 min with 100 nM natural TeTxL almost com-
pletely blocked Ca2+ evoked vasopressin release 
(Fig. 1). Under these conditions vasopressin release 
was enhanced only approximately l.3-fold by calcium 
(see Figs 1-5). The reeombinant WT light ehain also 
blocked Ca2+ induced vasopressin release from the 
permeabilized nerve terminals (Fig. 1). After pretreat-
ment with 100 nM recombinant tetanus toxin light 
ehain vasopressin release was inereased 1.3-fold by 
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10 flM Ca2+. Thus, when applied at a concentration 
of 100 nM, natural and reeombinant tetanus toxin 
light chains are equally effective in blocking Ca2+ 
indueed vasopressin release. 
In the next step we carried out functional exper-
iments with recombinant TeTxLs modified within the 
HELIH motif which is shared with a variety of zinc 
peptidases.30 We found that replacement of histidine 
233 by cysteine or valine (mutants H233C or H 233V) 
abolished the effect of the tetanus toxin light chain on 
Ca2+ indueed vasopressin release (Fig. 1). Thus it 
appears that the biological activity of the TeTxL is 
linked to the presenee of histidine 233 within the 
putative zinc binding HELIH motif. 
If TeTxL acts as a zinc peptidase during the 
inhibition of vasopressin release from the terminals, 
removal of zinc was expected to abolish its activity. 
Medium B (see Experimental Proeedures) used 
during the experiments, due to impurities in the 
chemicals, contains 2 fl M zinc (determined by atomic 
absorption spectroscopy) as well as 5 mM EDT A and 
0.5 mM EGT A as chelating agents. Thus TeTxL is 
exposed prior to and during the experiments to 
EDTA and EGTA which bind zinc with high affinity. 
Free zine in medium B, ealculated as deseribed24 is 
actually lower than 10 pM. Despite this low value, 
calcium induced vasopressin release was effectively 
blocked by natural and recombinant (WT) TeTxLs. 
To investigate a possible role of zinc in the action 
of the TeTx, we added a variety of other potent 
chelating agents for zinc. In the presence of both 
TeTx and 100 JlM of the zine chelator diethyldithio-
carbamate (DDC) vasopressin release was enhanced 
by Ca2+ approximately 2.3-fold (from 67 ± 1 pg to 
Contral 0 
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H233V 
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Fig. I. Effect of natural and different recombinant TeTxL on vasopressin release from permeabilized nerve 
terminals. After permeabilization with streptolysin 0, the isolated nerve terminals were slowly perifused 
for 30 min (see Experimental Proeedures) with medium B (eontrol), 100 nM natural (TeTxL) or 
reeombinant TeTxL in medium B. After 16 min the nerve terminals were challenged with medium B 
containing 10 JlM free Ca2+ (arrow). In the control experiments Ca2+ eaused within 16min an increase 
in vasopressin release from 46 ± 3 pg to 236 ± 13 pg, mean of three experiments). The release of 
vasopressin was completely abolished by 100 nM natural TeTxL (vasopressin release was enhanced by 
calcium from 69 ± 10 pg to 76 ± 17 pg, mean ofthree experiments). Following pretreatment with 100 nM 
WT recombinant TeTxL 81 ± II pg (n = 7) vasopressin was released during the first 16 min whieh was 
increased by 10 Jl M Ca2+ only to 106 ± 17 pg. Nerve terminals eXPosed to 100 nM mutant H213C (histidine 
233 replaced by cysteine) or H213V (histidine replaeed by valine) vasopressin release induced by calcium 
was similar in magnitude as in the eontrol (mean of four experiments). 
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Fig. 2. OPA completely inactivates the TeTxL; OPA (100 JlM) alone does not modify calcium induced 
vasopressin release but the effect of TeTxL is almost completely abolished by OPA. Vasopressin release 
was similar in the presence and in the absence ofOPA (values in brackets).1t was enhanced by Ca2+ from 
38 ± 4 pg (42 ± 4 pg) to 268 ± 24 pg (306 ± 36 pg). Vasopressin release is enhanced by Ca2+ in the presence 
of 100 nM TeTxL alone from 32 ± I pg to 73 ± 12 pg, and from 41 ± 5 pg to 287 ± 48 pg in the presence 
of both TeTxL and OPA. Vasopressin release in each group represents the mean of four experiments. 
152 ± 12 pg) whereas, in the presence of the light 
chain alone, it was enhanced l.3-fold (see above). 
DDC alone did not affect vasopressin release. These 
observations show that DDC, a strong chelating 
agent for zinc, diminished the effect of the TeTxL by 
approximately 50%. By contrast, DP A, a chelating 
agent which displays high affinity for zinc and low 
affinity for calcium and magnesium,) completely 
abolished the inhibititory effects of TeTxL when used 
at a concentration of 10011 M (Fig. 2). The release of 
vasopressin induced by calcium, in the presence of 
DPA alone or in the presence of both DPA and 
tetanus toxin light chain was the same as in the 
control experiments. Thus it can be conc1uded that 
very potent agents chelating zinc such as DPA are 
required to prevent the TeTxL action in neurohypo-
physial nerve endings. We determined the amounts of 
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zinc in the TeTxL preparation in the presence of 
5 mM EDT A and 0.5 mM EGT A (medium B, see 
Experimental Procedures) and found that it con-
tained 0.68 atoms zinc per mole TeTxL. Following 
treatment with IOOIlM DPA we measured 0.05 
atoms zinc per mole TeTxL. This indicates that zinc 
is effectively removed from TeTxL by DPA, a che1at-
ing agent which blocks the effect of TeTxL on 
vasopressin release. 
Incubation of permeabilized neurosecretosomes in 
the presence of the zinc peptidase inhibitor capto-
pri1 11 •15 did not infiuence vasopressin release but 
captopril abolished the inhibitory effect of the TeTxL 
when applied together (Fig. 3). These data further-
more support the eoncept, that the TeTxL acts as a 
zine peptidase during inhibition of exoeytosis of 
seeretory granules. 
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Fig. 3. Captopril abolishes the action of the TeTxL. While TeTxL almost completely blocks calcium 
induced vasopressin release, captopril, a potent inhibitor of zinc containing peptidases, abolished the effect 
of the neurotoxin light chain. In the presence of both I mM captopril and 100 nM tetanus toxin and in 
the control experiments performed in the presence of 1 mM captopril alone (value in brackets) vasopressin 
release was enhanced by Ca2+ from 64 ± 15 pg (68 ± 3 pg) to 265 ± 23 pg (227 ± 19 pg). Vasopressin 
release is enhanced by Ca2+ in the presence of 100 nM TeTxL alone from 77 ± 6 pg to 99 ± 20 pg. Oata 
are mean of four experiments of each group. 
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Fig. 4. Synthetic peptides corresponding to a motif present in synaptobrevin land 2 abolish the effect 
of the TeTxL. Ca2+ -induced vasopressin release was studied in the presence of 100 JlM ASQFETs or 
peptide I (DALQAGASVFESSAAKLKRK). While vasopressin release was blocked by 100nM TeTxL, 
this etfect was prevented by ASQFETS and peptide I. In the presence of both ASQFETS and TeTxL, 
vasopressin release was enhanced by Ca2+ from 438 ± 24 pg to 1130 ± 46 pg. In the presence of both 
peptide land TeTxL, vasopressin release was enhanced by Ca2+ from 416 ± 17 pg to 1205 ± 97 pg. The 
peptides alone did not inftuence Ca2+ induced vasopressin release. Data are mean of four experiments of 
each group. Vasopressin release was enhanced by Ca2+ in the presence of 100 nM TeTxL alone from 
399 pg to 449 pg (two ellperiments) and in the absence of the TeTxL from 319 ± 21 pg to 1105 ± 89 pg. 
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Co-incubation of the neurosecretosomes with the 
peptide ASQFETS (100 JlM), which contains the 
postulated site of synaptobrevin 2 c1eaved by tetanus 
toxin in vitro,43 specifically abolished the inhibitory 
action of the TeTxL on vasopressin release (Fig. 4) 
but not on catecholamine release from adrenal chro-
maffin cells (Höhne-Zell et al., unpublished obser-
vations). Similar results were obtained with QFET 
(not shown) and a 20-mer (peptide 2) containing the 
same sequence (DALQAGASQFETSAAKLKRK, 
Fig. 5). However, a 20-mer corresponding to an 
analogous site of synaptobrevin I (peptide 1: 
4) indicating that peptides derived from both 
known members of the synaptobrevin family4 com-
pete with the target of TeTxL within neurohypo-
physial terminals. 
DALQAGASVFESSAAKLKRK) also prevented 
the effect of the TeTxL on vasopressin release (Fig. 
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DISCUSSION 
Link between tetanus toxin light chain, synaptobrevin 
and exocytosis of secretory granules 
Recent evidence suggests that the inhibition of 
neurotransmitter release from synaptic vesic1es by the 
tetanus toxin light chain may be causally linked 10 the 
cleavage of the synaptic vesic1e membrane protein 
24 32 
time (min) 
Control 0 
PEPTIDE 2 + TeTx L <> 
TeTxL • 
40 48 
Fig. 5. A 20-amino acid peptides corresponding to a motif present in synaptobrevin 2 abolishes the etfect 
of the TeTxL. While vasopressin release was b10cked by 100 nM TeTxL, this effect was prevented by 
100JlM peptide 2 (DALQAGASQFETSAAKLKRK). In the presence of both peptide 2 and TeTxL 
vasopressin release was enhanced by Ca2+ from 219 ± 4 pg to 800 ± 25 pg. Peptide 2 alone did not 
inftuence Ca2+ induced vasopressin release. Data are mean of four experiments of each group. Vasopressin 
release was enhanced by Ca2+ in the presence of 100 nM TeTxL alone from 260 ± 13 pg to 370 ± 29 pg 
(six experiments) and in the absence of the TeTxL from 190 ± 9 pg to 926 ± 36 pg (six experiments). 
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synaptobrevin 2 and/or the covalent modification of 
the synaptic vesicle protein synapsin J.21.22.32.43,44 
Synaptobrevin and other membrane proteins of se-
cretory organelles are present exclusively in neural 
and endocrine cells but not in exocrine cells29.52 wh ich 
appears to correlate with the observation that exo-
cytosis by exocrine cells is insensitive to clostridial 
neurotoxins.48 Since we found that synthetic peptides 
containing the proposed synaptobrevin 2 cleavage 
si te and the corresponding sequence of synaptobrevin 
I block the inhibition of vasopressin release by the 
TeTxL, synaptobrevins are probably critical for exo-
cytosis and represent the prime target of tetanus toxin 
in neurohypophysial nerve endings. 
Release of secretory products stored in synaptic 
vesicles and secretory granules from many, if not all, 
terminals of the central nervous system is inhibited by 
clostridial neurotoxins. 26,J6 In addition, data pub-
lished on the inhibition of exocytosis from within 
nerve terminals or endocrine cells by the light chains 
of the neurotoxins imply that both synaptic vesicle 
and secretory granule membranes contain mem-
brane pro teins attacked by the neurotoxins' light 
chains. I .2,16,18.48-51 However, the membrane compo-
sition of synaptic vesicles and secretory granules is 
different29,52 and only a few membrane proteins such 
as synaptotagmins have been reported to be present 
in both types of secretory vesicles.29,52.53 While synap-
totagmin has consistently been found in adrenal 
chrom affin granules,2J,J4.46 positive23 and negativeJ9 
reports exist for neurohypophysial secretory gran-
ules. Synaptotagmins like synaptobrevins and other 
secretory vesicle membrane proteins are apparently 
members oflarger families differentially distributed in 
the CNS.20,25,58 Two reports suggest that some mem-
bers ofthe synaptobrevin family are absent in adrenal 
and neurohypophysial secretory granules.5.13 How-
ever, the immunocytochemical techniques applied in 
these studies may not have been suitable to detect 
other members of the synaptobrevin family, which 
may subserve the same function. Indeed very recently 
a ubiquitous further member of the synaptobrevin 
family was detected which can be cleaved by tetanus 
toxin. 15 
Investigations of the mechanism by which 
clostridial neurotoxins inhibit exocytosis of secretory 
granules (this study) and synaptic vesicles32,43,44 
suggest that synaptobrevins are essential components 
of the secretory machinery, TeTxL can be used as a 
tool to further dissect the molecular events during 
secretory vesicle docking and fusion and to find out 
how members ofthe synaptobrevin family participate 
in secretory granule and synaptic vesicle exocytosis, 
In this context it is interesting to note that synapto-
brevins, in contrast to synaptotagmins,6,27 apparently 
interact via the interrnediary of the N -ethyl-
maleimide-sensitive fusion pro tein (NSF) and the 
soluble NSF attachment protein (SNAP) complexes 
with cytoplasmic domains of acceptor membrane 
proteins of the plasmalemma,47 
Mode ol action ol clostridial toxin light chains 
Our data indicate that the TeTxL acts as a zinl:-
containing peptidase du ring inhibition of exocytosis 
of secretory granules, This conclusion is supported by 
the observations that (i) mutation of the histidine 
residue 233 of the TeTxL which constitutes the metal 
binding site, (ii) a ehelating agent for Zn2+ (DPA). 
and (iii) an inhibitor of zine peptidases (captopril), 
delete the inhibition of exoeytosis by the neurotoxin 
light ehain. 
The observations documented in this study are 
compatible with the accumulated knowledge on the 
properties of clostridial neurotoxins, The amino acid 
sequences of five different types of botulinum neuro-
toxins and of tetanus toxin have only a few similar 
domains,40 However, the motif HELIH (residues 
233-237) ofthe light chains is conserved and is shared 
with typical zinc proteases,lO Indeed, binding of zinc 
to the light chain of tetanus toxin and botulinum A 
toxin and to synthetic peptides containing the 
HELIH motif has recently been characterized45.59 
(Niemann et al" unpublished observation). Prelimi-
nary data show that the histidine 233 mutants contain 
less zinc than the WT TeTxL (Yamaski et al" unpub-
lished observation), The mutational analysis of the 
TeTxL carried out in the present study clearly indi-
cates, that histidine 233 is of paramount importance 
for the biological activity, as are equivalent histidine 
residues in the metal binding site of other zinc 
enzymes,14,54 Surprisingly, injected mRNA encoding 
histidine 233 mutated TeTxL abolished neurotrans-
mission in Aplysia neurons.7 The reason for this effect 
is at present unclear. However, the amounts of 
translated TeTxL in these neurons could be several-
fold higher compared to the well-controlled concen-
trations used in permeabilized neurohypophysial 
nerve terminals, Binding of mutated TeTxL to sub-
strates present on synaptic vesicles or modification of 
cytoskeleton/synaptic vesicle interactions21.22 could 
have caused the effect on release. 
Depletion of zine from the TeTxL by chelators 
abolished the inhibition of neurotransmitter release 
by Aplysia neurons,44 However, in previous investi-
gations reported from this groupl.2,16,18.48-51 as weil as 
in the present investigation, TeTxL was kept in media 
with anionic chelating agents such as EGT A, EDT A 
or nitrilotriacetic acid prior to and du ring the release 
experiments (see Experimental Procedures), Using 
this protocol, the TeTxL was fully active, suggesting 
that zine is not effectively removed by these ehelating 
agents, Indeed the measurements reported in this 
study show that zine remains bound to TeTxL under 
these conditions, Stronger complexing substances for 
zinc (such as DDC, used in this study) were also only 
partly effective but DP A which effectively removes 
zinc from TeTxL (this study) was very potent in 
deleting the effect of the TeTxL on vasopressin 
release, The requirement of a strong additional 
chelating agent for zinc in order to effectively block 
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the action of the TeTxL suggests that the affinity of 
the light ehain for zine in media suitable to replaee the 
intraeellular fluid may be higher than reported. 59 The 
importance of zine in the aetive site of TeTxL is 
further supported by the effeetiveness of eaptopril, 
which via its sulfhydryl group eomplexes the zine ion 
in the aetive center of metallopeptidases ll ,15 and 
inhibits the function of the neurotoxin in exocytotie 
release of vasopressin (this study), as weil as the 
cleavage of synaptobrevin.32,43 
CONCLUSION 
In summary, we believe that TeTxL aets as a zine 
peptidase within neurohypophysial nerve terminals 
and that its prime target in inhibiting seeretory 
granule exocytosis is one or several members of the 
synaptobrevin family. It is suggested that neuro-
hypophysial seeretory granules and synaptie vesicles 
share these essential components in their exocytotic 
pathway. 
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